Robert Barrow

Robert Barrow

Chief Executive Officer en MIND MEDICINE (MINDMED) INC. .

Fortuna: 5 M $ al 31/03/2024

Health Technology
Consumer Services
Commercial Services

Perfil

Robert Barrow is currently the Chief Executive Officer & Director at Mind Medicine (MindMed), Inc. since 2021.
He is also the Owner of Jasper Biopharmaceutical Advisors LLC since 2018.
Previously, he served as the Director-Drug Development at Promega Corp.
from 2019 to 2020 and as the Director-Drug Development & Discovery at Usona Institute from 2019 to 2020.
He was also the Chief Operating Officer at Olatec Therapeutics LLC and the Chief Financial Officer at Olatec Therapeutics LLC from 2009 to 2018.
Mr. Barrow received his undergraduate degree from Wake Forest University and his graduate degree from The Ohio State University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
25/03/2024 580 202 ( 0.82% ) 5 M $ 31/03/2024

Cargos activos de Robert Barrow

EmpresasCargoInicio
MIND MEDICINE (MINDMED) INC. Chief Executive Officer 09/06/2021
Jasper Biopharmaceutical Advisors LLC Corporate Officer/Principal 01/01/2018
Todos los cargos activos de Robert Barrow

Antiguos cargos conocidos de Robert Barrow.

EmpresasCargoFin
Corporate Officer/Principal 01/07/2020
Corporate Officer/Principal 01/01/2020
Director of Finance/CFO 01/01/2018
Chief Operating Officer -
Ver el detalle de la experiencia de Robert Barrow.

Formación de Robert Barrow.

Wake Forest University Undergraduate Degree
The Ohio State University Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Robert Barrow.

Relaciones

30

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
MIND MEDICINE (MINDMED) INC.

Health Technology

Empresas privadas4

Health Technology

Commercial Services

Health Technology

Jasper Biopharmaceutical Advisors LLC

Ver las conexiones de la empresa